Erik Boot

Maastricht, LI, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 84 publications

Early-Onset Parkinson's Disease with 22q11.2 Microdeletion and Pathogenic GBA1 Variant.

Early-Onset Parkinson's Disease with 22q11.2 Microdeletion and Pathogenic GBA1 Variant.

Journal: Movement disorders clinical practice

Published: April 23, 2026

Deletion size and background genetic variation shape congenital heart disease phenotypes in 3,016 individuals with 22q11.2 deletion syndrome.

Deletion size and background genetic variation shape congenital heart disease phenotypes in 3,016 individuals with 22q11.2 deletion syndrome.

Journal: medRxiv : the preprint server for health sciences

Published: March 27, 2026

Deletion size and background genetic variation shape congenital heart disease phenotypes in 3,016 individuals with 22q11.2 deletion syndrome.

Deletion size and background genetic variation shape congenital heart disease phenotypes in 3,016 individuals with 22q11.2 deletion syndrome.

Journal: medRxiv : the preprint server for health sciences

Published: March 27, 2026

Multicenter retrospective study on effectiveness, reported side effects, and cognitive outcomes of SSRIs in 22q11.2 deletion syndrome.

Multicenter retrospective study on effectiveness, reported side effects, and cognitive outcomes of SSRIs in 22q11.2 deletion syndrome.

Journal: Research square

Published: January 09, 2026

Serum NfL, GFAP, and p-tau217 in adults with drug-resistant epilepsy and intellectual disabilities: Signs of ongoing neural injury.

Serum NfL, GFAP, and p-tau217 in adults with drug-resistant epilepsy and intellectual disabilities: Signs of ongoing neural injury.

Journal: Epilepsia

Published: December 23, 2025

Multicenter retrospective study on perceived effectiveness, reported side effects, and cognitive outcomes of SSRIs in 22q11.2 deletion syndrome.

Multicenter retrospective study on perceived effectiveness, reported side effects, and cognitive outcomes of SSRIs in 22q11.2 deletion syndrome.

Journal: European child & adolescent psychiatry

Published: December 05, 2025

Prevalence and Spectrum of Congenital Heart Disease in Individuals With Distal Chromosome 22q11.22-23 Deletions.

Prevalence and Spectrum of Congenital Heart Disease in Individuals With Distal Chromosome 22q11.22-23 Deletions.

Journal: Clinical genetics

Published: October 06, 2025

Towards Personalised Care for Rare Genetic Disorders.

Towards Personalised Care for Rare Genetic Disorders.

Journal: Journal of intellectual disability research : JIDR

Published: July 29, 2025

Movement Disorders Associated with 22q11.2 Microdeletion: A Scoping Review.

Movement Disorders Associated with 22q11.2 Microdeletion: A Scoping Review.

Journal: Movement disorders clinical practice

Published: June 14, 2025

Dissecting the Phenotypic Spectrum and Complexity of Movement Disorders in 22q11.2 Deletion Syndrome.

Dissecting the Phenotypic Spectrum and Complexity of Movement Disorders in 22q11.2 Deletion Syndrome.

Journal: European journal of neurology

Published: February 01, 2025

Real-World Treatment of Schizophrenia in Adults With a 22q11.2 Microdeletion: Traitement dans le monde réel de la schizophrénie chez des adultes atteints du syndrome de microdélétion 22q11.2.

Real-World Treatment of Schizophrenia in Adults With a 22q11.2 Microdeletion: Traitement dans le monde réel de la schizophrénie chez des adultes atteints du syndrome de microdélétion 22q11.2.

Journal: Canadian journal of psychiatry. Revue canadienne de psychiatrie

Published: December 06, 2024

Cognitive, adaptive and daily life functioning in adults with 22q11.2 deletion syndrome.

Cognitive, adaptive and daily life functioning in adults with 22q11.2 deletion syndrome.

Journal: BJPsych open

Published: November 11, 2024

Showing 1-12 of 84

Last Updated: 09/26/2026